DTC: Direct to Children?
By Katie Stoll,
The DNA Exchange
| 05. 10. 2018
Last week Phil Rogers, of Chicago NBC News reported that he submitted a DNA sample from his dog, Baily, to the laboratory, Orig3n for analysis. This made headlines because a test report was issued on his dog for a test that was designed and marketed for humans. In follow-up to the story, Orig3n spokesperson, Karmen Conrad stated that, “…since October Orig3n has acquired a CLIA Certified laboratory and upon hearing about this issue has implemented controls to assure that nefarious samples such as this are rejected from further processing. We are sorry there was an error in reporting this one particular sample.”
I know firsthand that Phil’s experience was not an isolated case.* Last December, I submitted my dog Ginger’s DNA swab for the “Bloom Child Development” test, also by Orig3n, and I also received a completed test report. According to Orig3n’s website, “the Child Development DNA Test is a gene profile that will start you and your child on the path to lifelong discovery. From fitness to natural abilities for language and learning, the results help you... see more
Related Articles
By Gina Kolata, The New York Times | 12.05.2022
In a bold attempt to stop the progress of some cases of Alzheimer’s disease, a group of researchers is trying something new — injecting a protective gene into patients’ brains.
The trial involved just five patients with a particular genetic...
By Nick Paul Taylor, Fierce Biotech | 12.05.2022
The FDA has set out its reasons for putting Verve Therapeutics’ high cholesterol gene editing therapy on hold. Officials want additional data to allay concerns that patients could pass on the edited genes to their children before they lift the...
By Emily Mullin, Wired | 12.05.2022
Some of Steven Pipe’s hemophilia patients consider themselves cured. In a trial Pipe led from 2018 to 2021, they received a one-time gene therapy meant to override a DNA mutation that causes spontaneous bleeding episodes, some of them severe and...
By Jessica Hamzelou, MIT Technology Review | 11.16.2022
“Who wants to live forever?” The immortal words of Freddie Mercury blast from the speakers as blue lights swivel around the room and a smoky mist floats up from the stage in front of me. If the audience is anything...
